0001053310-22-000002.txt : 20220511
0001053310-22-000002.hdr.sgml : 20220511
20220511143726
ACCESSION NUMBER: 0001053310-22-000002
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220506
FILED AS OF DATE: 20220511
DATE AS OF CHANGE: 20220511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAY E GERALD
CENTRAL INDEX KEY: 0001053310
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31668
FILM NUMBER: 22913222
MAIL ADDRESS:
STREET 1: C/O 225 LONG AVENUE
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC
CENTRAL INDEX KEY: 0001016504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222407475
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
BUSINESS PHONE: 9739260816
MAIL ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC
DATE OF NAME CHANGE: 20020912
FORMER COMPANY:
FORMER CONFORMED NAME: CHEM INTERNATIONAL INC
DATE OF NAME CHANGE: 19960716
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4/A
2022-05-06
2022-05-06
0
0001016504
INTEGRATED BIOPHARMA INC
inbp
0001053310
KAY E GERALD
C/O 225 LONG AVENUE
HILLSIDE
NJ
07205
1
1
1
0
Executive Chairman & President
Common Stock
2022-05-06
4
M
0
100000
0.23
A
5345889
D
Stock Option (right to buy)
0.23
2022-05-06
4
M
0
100000
0
D
2024-05-24
Common Stock
100000
150000
D
This Form 4 is being amended to correct the Transaction Code in Table 1 and to include the previously inadvertently omitted disclosure in Table II.
100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019.
The option vested 50% (125,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (125,000) beginning on May 24, 2020 and ending May 24, 2022.
/s/ E. Gerald Kay
2022-05-11